Company: NDRA
Filing Date: 2025-11-06
Form Type: S-3
Source: 0001213900-25-107232
Chunk: 46

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-06
Form: S-3
Chunk 46
---
 previously disclosed in the registration statement           
 or any material change to such information in the registration statement; provided, however,         
 that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the information          
 required to be included in a post-effective amendment by those paragraphs is contained in            
 reports filed with or furnished to the Securities and Exchange Commission by the registrant          
 pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated 
 by reference in the registration statement, or is contained in a form of prospectus filed            
 pursuant to Rule 424(b) that is a part of the registration statement.                                |

provided, however, that paragraphs (a)(1)(i),
(a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or
Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained
in a form of prospectus filed pursuant to Rule 424(b) that is a part of the registration statement.

<div align='center'>II-4</div>

| (2) | That, for the purpose of determining                                                         
 any liability under the Securities Act of 1933, each such post-effective amendment shall     
 be deemed to be a new registration statement relating to the securities offered therein,     
 and the offering of such securities at that time shall be deemed to be the initial bona fide 
 offering thereof.                                                                            |

| (3) | To remove from registration by means                                                     
 of a post-effective amendment any of the securities being registered which remain unsold 
 at the termination of the offering.                                                      |

| (4) | That, for the purpose of determining                                           
 liability of the registrant under the Securities Act of 1933 to any purchaser: |

| (i) | Each prospectus filed by the registrant                                                      
 pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of    
 the date the filed prospectus was deemed part of and included in the registration statement; 
 and                                                                                          |

| (ii) | Each prospectus required to be filed pursuant                                                      
 to Rule 424(b)(2), 424(b)(5